Eight-Year Post-Trial Outcomes of a Two-Year Clinical Trial of DIMS Spectacle Lenses
Ophthalmic and Physiological Optics · 15.08.2026
DOI: 10.1007/s44402-026-00170-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmic and Physiological Optics, online erschienen am 15.08.2026. Verfasst von Han Yu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin, China. hanyuzhang@nankai.edu.cn. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HOYA Corporation, InnoHK initiative and the Hong Kong Special Administrative Region Government.
Abstract (Originalsprache)
PURPOSE: This observational follow-up evaluated the long-term efficacy of Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in children over 8 years and identified factors that influence the treatment response, particularly baseline relative peripheral refraction (RPR). METHODS: Data from an 8-year study of DIMS lens myopia control effectiveness was reviewed retrospectively. Participants were analysed by types of lens wear (DIMS vs. single vision (SV)) and categorised by baseline RPR. Effectiveness was calculated by comparing the 8-year DIMS subgroup against historical controls, with analyses including and excluding participants with myopic RPR. RESULTS: Sixty participants who completed the previous 6-year follow up, attended the 8+ year investigation: 38 and 22 exhibited hyperopic and myopic RPR at baseline, respectively. Among continuous DIMS lens wear (n = 14) for the whole period, the myopic RPR subgroup (n = 4) showed statistically significantly greater axial elongation than the hyperopic RPR subgroup (n = 10) between 6 to 8+ years (mean difference: 0.17 ± 0.06 mm, p = 0.009). Excluding myopic RPR participants, DIMS wearers exhibited a statistically significant reduction in axial elongation compared with SV wearers (mean difference: 0.13 ± 0.05 mm, p = 0.009), though myopia progression did not differ significantly (p = 0.12). Over the full 8+ year period, DIMS wearers with hyperopic RPR (n = 10) achieved a 56% myopia control effectiveness compared with the historical control group (n = 62), with a statistically significant reduction in axial elongation of 0.57 mm (p < 0.0001). CONCLUSIONS: This study represents the longest post-trial follow-up investigation of DIMS spectacle lenses for myopia control to date. Baseline RPR modified the long-term response to DIMS spectacle lenses: children with myopic RPR showed reduced efficacy and may require alternative or adjunctive strategies, whereas in those with hyperopic RPR, treatment effect was maintained for more than 8 years, extending beyond childhood into young adulthood. Therefore, baseline RPR assessment may inform personalised myopia control prescribing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin, China. hanyuzhang@nankai.edu.cn.
- Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Hong Kong, Hong Kong SAR. hanyuzhang@nankai.edu.cn.
- Institute of Optometry and Vision Science, School of Medicine, Nankai University, Tianjin, China. hanyuzhang@nankai.edu.cn.
- Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Hong Kong, Hong Kong SAR.
- Centre for Eye and Vision Research (CEVR), Hong Kong, Hong Kong SAR.
- Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
Förderung
- HOYA Corporation
- InnoHK initiative and the Hong Kong Special Administrative Region Government
Zitieren
APA
Zhang, H. Y., Leung, T. W., Lee, P., Liu, K. K. K., Kwok, Y. M., To, K. M., Lam, C. S. Y., & Vlasak, N. (2026). Eight-Year Post-Trial Outcomes of a Two-Year Clinical Trial of DIMS Spectacle Lenses. Ophthalmic and Physiological Optics. https://doi.org/10.1007/s44402-026-00170-9
Vancouver
Zhang HY, Leung TW, Lee P, Liu KKK, Kwok YM, To KM, et al. Eight-Year Post-Trial Outcomes of a Two-Year Clinical Trial of DIMS Spectacle Lenses. Ophthalmic and Physiological Optics. 2026. doi:10.1007/s44402-026-00170-9
BibTeX
@article{Zhang2026,
author = {Zhang, Han Yu and Leung, Tsz Wing and Lee, Paul and Liu, Kenneth Ka King and Kwok, Yee Mui and To, Ka Mei and Lam, Carly Siu Yin and Vlasak, Natalia},
title = {Eight-Year Post-Trial Outcomes of a Two-Year Clinical Trial of DIMS Spectacle Lenses},
journal = {Ophthalmic and Physiological Optics},
year = {2026},
doi = {10.1007/s44402-026-00170-9}
}
EUVIMED